4
Changes in Ownership
Summit Therapeutics Inc. Filed Acc 0000921895-20-002868
Chief Executive Officer bought 14,071,856 shares at $3.34 ($46,999,999)
From the SEC's structured data for this filing
Trades in this filing
DUGGAN ROBERT W · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-11-06 | Purchase : show line 1 in the form | +14,071,856 | $3.34 | $46,999,999 | 56,296,533 | D |
| Open-market purchases · 14,071,856 sh · avg $3.34 · $46,999,999 | ||||||
Loading xslF345X03/form412566001_11102020.xml…